Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413905427> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2413905427 endingPage "22" @default.
- W2413905427 startingPage "S19" @default.
- W2413905427 abstract "High-dose chemotherapy is a policy which is increasing in the field of solid tumors both in Europe and in North America. Hundreds of patients undergo ABMT or PBPCT in Europe every year especially for breast carcinoma. Waiting for the results of several ongoing trials, high-dose chemotherapy has shown to be of extreme interest in the adjuvant setting of patients with high risk breast cancer in phase II trials. The best results had been reported by Peters and Gianni; with a minimum follow-up of 5 years 65 and 56% of their patients with ten or more axillary lymph nodes are alive disease free. These results are better than any others with standard doses. The only one published trial (from South Africa) on advanced disease clearly favours high-doses of cyclophosphamide, mitoxantrone and etoposide versus standard doses of cyclophosphamide, mitoxantrone and vincristine in terms of overall survival and time to relapse. The use of PBPC replacing ABMT has allowed an easier tolerability of the procedure and a reduction of the costs. There is a clear reduction of the toxic death rate to 1% in 1995 for breast cancer patients compared with 20% of fifteen years ago. Germ cell tumors in responding relapse after salvage chemotherapy seem to be ideal candidates for ABMT/PBPC programs with an expected 40% disease free survival. The clinical impact of the PBPC contamination by tumor cells is still nowadays a matter of debate at least for breast carcinoma and neuroblastoma. This review will focus on the present situation of high-dose chemotherapy for solid tumors with some insights to new technologies and their applications." @default.
- W2413905427 created "2016-06-24" @default.
- W2413905427 creator A5010700449 @default.
- W2413905427 creator A5018226027 @default.
- W2413905427 creator A5023055484 @default.
- W2413905427 creator A5028269615 @default.
- W2413905427 creator A5057649253 @default.
- W2413905427 creator A5077189840 @default.
- W2413905427 creator A5082306007 @default.
- W2413905427 creator A5082776045 @default.
- W2413905427 creator A5085427107 @default.
- W2413905427 creator A5087455044 @default.
- W2413905427 date "1996-03-01" @default.
- W2413905427 modified "2023-09-27" @default.
- W2413905427 title "[High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors]." @default.
- W2413905427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8928234" @default.
- W2413905427 hasPublicationYear "1996" @default.
- W2413905427 type Work @default.
- W2413905427 sameAs 2413905427 @default.
- W2413905427 citedByCount "0" @default.
- W2413905427 crossrefType "journal-article" @default.
- W2413905427 hasAuthorship W2413905427A5010700449 @default.
- W2413905427 hasAuthorship W2413905427A5018226027 @default.
- W2413905427 hasAuthorship W2413905427A5023055484 @default.
- W2413905427 hasAuthorship W2413905427A5028269615 @default.
- W2413905427 hasAuthorship W2413905427A5057649253 @default.
- W2413905427 hasAuthorship W2413905427A5077189840 @default.
- W2413905427 hasAuthorship W2413905427A5082306007 @default.
- W2413905427 hasAuthorship W2413905427A5082776045 @default.
- W2413905427 hasAuthorship W2413905427A5085427107 @default.
- W2413905427 hasAuthorship W2413905427A5087455044 @default.
- W2413905427 hasConcept C121608353 @default.
- W2413905427 hasConcept C126322002 @default.
- W2413905427 hasConcept C141071460 @default.
- W2413905427 hasConcept C143998085 @default.
- W2413905427 hasConcept C2776694085 @default.
- W2413905427 hasConcept C2776755627 @default.
- W2413905427 hasConcept C2778119113 @default.
- W2413905427 hasConcept C2779429289 @default.
- W2413905427 hasConcept C2780923524 @default.
- W2413905427 hasConcept C530470458 @default.
- W2413905427 hasConcept C71924100 @default.
- W2413905427 hasConceptScore W2413905427C121608353 @default.
- W2413905427 hasConceptScore W2413905427C126322002 @default.
- W2413905427 hasConceptScore W2413905427C141071460 @default.
- W2413905427 hasConceptScore W2413905427C143998085 @default.
- W2413905427 hasConceptScore W2413905427C2776694085 @default.
- W2413905427 hasConceptScore W2413905427C2776755627 @default.
- W2413905427 hasConceptScore W2413905427C2778119113 @default.
- W2413905427 hasConceptScore W2413905427C2779429289 @default.
- W2413905427 hasConceptScore W2413905427C2780923524 @default.
- W2413905427 hasConceptScore W2413905427C530470458 @default.
- W2413905427 hasConceptScore W2413905427C71924100 @default.
- W2413905427 hasIssue "2 Suppl" @default.
- W2413905427 hasLocation W24139054271 @default.
- W2413905427 hasOpenAccess W2413905427 @default.
- W2413905427 hasPrimaryLocation W24139054271 @default.
- W2413905427 hasRelatedWork W1964913429 @default.
- W2413905427 hasRelatedWork W2007523389 @default.
- W2413905427 hasRelatedWork W2047930003 @default.
- W2413905427 hasRelatedWork W2058651400 @default.
- W2413905427 hasRelatedWork W2060170707 @default.
- W2413905427 hasRelatedWork W2123955706 @default.
- W2413905427 hasRelatedWork W2252336101 @default.
- W2413905427 hasRelatedWork W2412181118 @default.
- W2413905427 hasRelatedWork W2467224484 @default.
- W2413905427 hasRelatedWork W2013648625 @default.
- W2413905427 hasVolume "82" @default.
- W2413905427 isParatext "false" @default.
- W2413905427 isRetracted "false" @default.
- W2413905427 magId "2413905427" @default.
- W2413905427 workType "article" @default.